University of Washington (UW) Medicine is taking part in a nationwide clinical trial testing whether GLP‑1 drugs for weight loss and diabetes could actually help people cut back on drinking. GLP-1 medications — widely recognized under brand names such as Ozempic or Wegovy — have surged in popularity for their ability to promote weight loss and improve blood sugar control. They’ve also been linked to reduced cardiovascular risk. Now, scientists a…